SCHEMBL6528072

SCHEMBL6528072

CC1=C(C(=O)O)C(c2cccc([N+](=O)[O-])c2)NC(=O)N1CCCC1CNC(=O)N1c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.54
HTT P42858 1/20 0.49
ATM Q13315 1/20 0.49
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
HSD17B10 Q99714 1/20 0.43
LMNA P02545 3/20 0.41
TSHR P16473 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
GUSB P08236 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6464167 0.74 ALDH1A1 (0.53) ALDH1A1HTTATMMAPTSMN1; SMN2
SCHEMBL6533654 0.74 ALDH1A1 (0.55) ALDH1A1HTTATMMAPTSMN1; SMN2
SCHEMBL6467200 0.73 ALDH1A1 (0.54) ALDH1A1HTTATMMAPTSMN1; SMN2
SCHEMBL6463902 0.73 ALDH1A1 (0.54) ALDH1A1HTTATMMAPTSMN1; SMN2
SCHEMBL6464188 0.71 ALDH1A1 (0.52) ALDH1A1HTTATMMAPTSMN1; SMN2
SCHEMBL6465916 0.70 ALDH1A1 (0.54) ALDH1A1HTTATMMAPTSMN1; SMN2
SCHEMBL392493 0.68 MAPT (0.84) ALDH1A1HTTATMMAPTSMN1; SMN2
SCHEMBL6465067 0.67 ALDH1A1 (0.47) ALDH1A1HTTATMMAPTSMN1; SMN2
SCHEMBL9814256 0.66 ALDH1A1 (0.62) ALDH1A1HTTATMMAPTCYP1A2
SCHEMBL8108247 0.66 ALDH1A1 (0.63) ALDH1A1HTTATMMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005009392-A2 DIHYDROPYRIMIDONE INHIBITORS OF CALCIUM CHANNEL FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2005-02-03 WO disclosed